Related Experiment Video
Updated: Aug 10, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the
1Center for Ligand and Transcription, Department of Biology, Chonnam National University, Kwangju, Korea.
Abstract:
ASC-2 was recently discovered as a cancer-amplified transcription coactivator molecule of nuclear receptors, which interacts with multifunctional transcription integrators steroid receptor coactivator-1 (SRC-1) and CREB-binding protein (CBP)/p300. Herein, we report the identification of three mitogenic transcription factors as novel target molecules of ASC-2. First, the C-terminal transactivation domain of serum response factor (SRF) was identified among a series of ASC-2-interacting proteins from the yeast two-hybrid screening. Second, ASC-2 specifically interacted with the activating protein-1 (AP-1) components c-Jun and c-Fos as well as the nuclear factor-kappaB (NFkappaB) components p50 and p65, as demonstrated by the glutathione S-transferase pull-down assays as well as the yeast two-hybrid tests. In cotransfection of mammalian cells, ASC-2 potentiated transactivations by SRF, AP-1, and NFkappaB in a dose-dependent manner, either alone or in conjunction with SRC-1 and p300. In addition, ASC-2 efficiently relieved the previously described transrepression between nuclear receptors and either AP-1 or NFkappaB. Overall, these results suggest that the nuclear receptor coactivator ASC-2 also mediates transactivations by SRF, AP-1, and NFkappaB, which may contribute to the putative, ASC-2-mediated tumorigenesis.
Insights
The cancer-associated coactivator ASC-2 interacts with transcription factors serum response factor (SRF), activating protein-1 (AP-1), and nuclear factor-kappaB (NFkappaB). ASC-2 enhances their activity and may play a role in tumorigenesis.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- ASC-2 (Amplifier of the Splicing Complex 2) is a known coactivator for nuclear receptors involved in cancer.
- It interacts with other coactivators like SRC-1 and CBP/p300.
- The full range of ASC-2's interactions and functions in gene regulation is not completely understood.
Purpose of the Study:
- To identify novel target molecules of the coactivator ASC-2.
- To investigate the interaction of ASC-2 with specific transcription factors.
- To determine the functional consequences of ASC-2's interactions on gene transactivation and its role in tumorigenesis.
Main Methods:
- Yeast two-hybrid screening to identify ASC-2 interacting proteins.
- Glutathione S-transferase (GST) pull-down assays to confirm interactions.
- Mammalian cell cotransfection assays to assess effects on gene transactivation.
Main Results:
- ASC-2 directly interacts with serum response factor (SRF), c-Jun/c-Fos (AP-1), and p50/p65 (NFkappaB).
- ASC-2 potentiates the transactivation activity of SRF, AP-1, and NFkappaB in a dose-dependent manner.
- ASC-2 alleviates transrepression between nuclear receptors and AP-1 or NFkappaB.
Conclusions:
- ASC-2 functions not only as a nuclear receptor coactivator but also mediates transactivation by SRF, AP-1, and NFkappaB.
- These newly identified interactions suggest a broader role for ASC-2 in gene regulation.
- ASC-2's involvement in the activation of these transcription factors may contribute to cancer development.
More Related Videos
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Co-activators and Co-repressors

